Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Low Grade Serous Ovarian Cancer × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 399 Carcinoma, Non-Small-Cell Lung 338 Neoplasms 311 Prostatic Neoplasms 268 Colorectal Neoplasms 206 Lung Neoplasms 203 Neoplasm Metastasis 181 Leukemia, Myeloid, Acute 176 Multiple Myeloma 163 Ovarian Neoplasms 155 Melanoma 138 Pancreatic Neoplasms 116 Squamous Cell Carcinoma of Head and Neck 109 Recurrence 105 Glioblastoma 94 Lymphoma 92 Brain Neoplasms 92 Triple Negative Breast Neoplasms 91 Endometrial Neoplasms 88 Carcinoma, Hepatocellular 88 Uterine Cervical Neoplasms 84 Stomach Neoplasms 84 Glioma 83 Carcinoma, Renal Cell 83 Urinary Bladder Neoplasms 80 Precursor Cell Lymphoblastic Leukemia-Lymphoma 80 Lymphoma, Non-Hodgkin 79 Sarcoma 73 Myelodysplastic Syndromes 73 Lymphoma, Follicular 72

Interventions

liposomal doxorubicin 1 defactinib 1 Paclitaxel 1 Letrozole 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06072781 2026-03-17

RAMP 301

Verastem, Inc.

Phase 3 Recruiting

Low Grade Serous Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡